DpC, a unique small molecule invented by Des Richardson and David Lovejoy at the University of Sydney has been shown to dramatically impair the growth of cancer cells in preclinical models (Company Web Page, Collaborative Medicinal Development, MAY 12, 2016, View Source [SID:1234512305]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!